MedTrace Logo

The Effects of Fenugreek Extract (Fenobet) on Metabolic Syndrome

NCT06114134 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2023-11-02

No results posted yet for this study

Summary

The current study is a three-blind, randomized clinical trial study that will be conducted on 60 people with metabolic syndrome. The eligible participants were allocated randomly to one of the two study groups (Fenobet, Placebo). Then, the eligible people were in one of two groups 1) receiving fenugreek extract, 2), receiving placebos and were examined for 8 weeks. At baseline and after two months of intervention, biochemical parameters, and anthropometric indices will be measured.

Conditions

  • Metabolic Syndrome
  • Complementary Therapies
  • Diabetes Mellitus, Type 2

Interventions

DIETARY_SUPPLEMENT

Fenobet

receiving fenugreek extract (3 capsules of 500 mg, 1 capsule half an hour before meals)

DIETARY_SUPPLEMENT

Placebo

Placebo

Sponsors & Collaborators

  • Tehran University of Medical Sciences

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-01
Primary Completion
2023-12-15
Completion
2024-02-20

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06114134 on ClinicalTrials.gov